# ZEEST BIO INC: Development of a Pre-Targeting Strategy for Liver Cancer Radionuclide Therapy

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | ZEEST BIO INC |
| Location | WATERTOWN, MA |
| Project | Development of a Pre-Targeting Strategy for Liver Cancer Radionuclide Therapy |
| Project number | 1R43CA310036-01A1 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $398,040 |
| Awarded | 2026-09-14 |
| Project period | 2026-09-14 to 2027-08-31 |
| UEI | US1ZAMC4JK65 |

## Why this score
- Award of $398,040.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11405078). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.